-
September 13: The Week in Cancer NewsSome cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.
by Kate Yandell
-
HIV Can Worsen Cancer Treatment OutcomesPeople with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
-
Immunotherapy in the ElderlyImmune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
-
Why Is the Rate of Uterine Cancer Rising?Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.
by Ashley P. Taylor
-
Cancer Care on a Native American ReservationFor the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.
by Kate Yandell
-
Forward Look
Pediatric Leukemia Treatments Are Not Just for KidsStudy supports using these regimens for teens and young adults.
by Bradley Jones
-
Forward Look
What’s Next? Summer 2019Probe may provide easier way to spot melanoma.
by Bradley Jones
-
Healthy Habits
Where There’s SmokeWhat to know before firing up the grill during barbecue season.
by Bradley Jones
-
Healthy Habits
Overlooking ObesityPublic awareness of the link between obesity and cancer risk is poor.
by Jane C. Hu
-
Proton Therapy Is Associated With Reduced Side EffectsWhen combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.
by Sue Rochman
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
